Mainstay Capital Management’s Labcorp LH Stock Holding History

Mainstay Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-233	Closed	-$35K	–	254
2018 Q3	$35K	Hold	233	–	–	0.02%	235
2018 Q2	$36K	Buy	+233	New	+$35.2K	0.03%	212

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mainstay Capital Management's LH Position: Q4 2018 in Review

Mainstay Capital Management sold out of Labcorp (LH) in Q4 2018, closing a stake of 233 shares — an estimated $35K sold.

Mainstay Capital Management first reported a position in LH in Q2 2018 and held it in 2 quarters. The position peaked at $36K in Q2 2018. 742 funds tracked by Wall St. Rank hold LH as of Q4 2018.

Mainstay Capital Management reported no remaining Labcorp position as of Q4 2018 after selling out during the quarter.
Mainstay Capital Management sold 233 Labcorp shares in Q4 2018, an estimated $35K.
Mainstay Capital Management first reported a position in Labcorp in Q2 2018 and held it in 2 quarters.
Mainstay Capital Management's Labcorp position peaked at $36K in Q2 2018.
742 funds tracked by Wall St. Rank held Labcorp as of Q4 2018.

Based on Mainstay Capital Management's 13F filing for Q4 2018, filed 8 Feb 2019.